Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody (Q65937995)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

title

Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Sean C Elias

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Angela Minassian

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Bruce Malcolm Russell

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

François Nosten

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Robert W Moon

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Matthew K. Higgins

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Simon J. Draper

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

17

Laurent Rénia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

author name string

Thomas A Rawlinson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Natalie M Barber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Franziska Mohring

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Jee Sun Cho

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Varakorn Kosaisavee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Daniel G W Alanine

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Geneviève M Labbé

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Sarah E Silk

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Doris Quinkert

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Jing Jin

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Jennifer M Marshall

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Ruth O Payne

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

language of work or name

1 reference

27 May 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

number of pages

11

1 reference

full work available at URL

inferred from page(s)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711757

1 reference

21 March 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

page(s)

1497-1507

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

A long neglected world malaria map: Plasmodium vivax endemicity in 2010

28 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax.

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

The unhealthy attraction of Plasmodium vivax to reticulocytes expressing transferrin receptor 1 (CD71).

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain.

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Targeting the Plasmodium vivax Duffy-binding protein.

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Targeted deletion of Plasmodium knowlesi Duffy binding protein confirms its role in junction formation during invasion.

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

The Resistance Factor to Plasmodium vivax in Blacks

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Plasmodium vivax Transmission in Africa

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Malaria Vaccines: Recent Advances and New Horizons

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC).

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Red blood cell invasion by Plasmodium vivax: structural basis for DBP engagement of DARC

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium Vivax

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Plasmodium vivax in vitro continuous culture: the spoke in the wheel

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

IgBLAST: an immunoglobulin variable domain sequence analysis tool

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Development of quantitative receptor-ligand binding assay for use as a tool to estimate immune responses against Plasmodium vivax Duffy binding protein Region II.

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Human red blood cell-adapted Plasmodium knowlesi parasites: a new model system for malaria research

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

The genome of the simian and human malaria parasite Plasmodium knowlesi

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Kinetic constraints on the development of a malaria vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Worldwide genetic variability of the Duffy binding protein: insights into Plasmodium vivax vaccine development

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Circular polymerase extension cloning of complex gene libraries and pathways

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag'.

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Plasmodium vivax Controlled Human Malaria Infection - Progress and Prospects

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Unambiguous determination of Plasmodium vivax reticulocyte invasion by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

1 reference

7 January 2021

Scaling and assessment of data quality

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Phasercrystallographic software

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Features and development of Coot

1 reference

https://api.crossref.org/works/10.1038%2FS41564-019-0462-1

7 January 2021

Rapid and iterative genome editing in the malaria parasite Plasmodium knowlesi provides new tools for P. vivax research.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/31133755

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/S41564-019-0462-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31133755%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

1 reference